Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia [1]

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 9, 2005, Pages 3980-3981

  Metan, Gokhan ^a   Uzun, Omrum ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE;

ADULT; ANTIMICROBIAL THERAPY; BACTEREMIA; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; LETTER; MALE; MORTALITY; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STENOTROPHOMONAS MALTOPHILIA; TREATMENT OUTCOME;

EID: 24144461672     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.9.3980-3981.2005     Document Type: Letter

References (4)

1. Kang, C.-I., S.-H. Kim, W. B. Park, et al. 2005. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob. Agents Chemother. 49:760-766.
2. Lai, C. H., C. Y. Chi, H. P. Chen, et al. 2004. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J. Microbiol. Immunol. Infect. 37:350-358.
3. Micozzi, A., M. Venditti, M. Monaco, A. Friedrich, F. Taglietti, S. Santilli, and P. Martino. 2000. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin. Infect. Dis. 31:705-711.
4. Senol, E., J. DesJardin, P. C. Stark, L. Barefoot, and D. R. Snydman. 2002. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin. Infect. Dis. 34:1653-1656.